Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Sarepta Therapeutics, Inc. (SRPT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Mar 2024
Arif Bilal
Chief Tech Ops Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
27,293
-6%
2,000
$128.84
$257,676.40
SELL
1 Mar 2024
Estepan Ian Michael
Chief Financial Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
39,114
-2%
1,200
$128.30
$153,960.00
SELL
1 Mar 2024
Brown Ryan Edward
EVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
31,827
-5%
2,000
$125.34
$250,680.00
BUY
3 Nov 2023
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
10,000
+125%
50,000
$78.81
$3,940,500.00
BUY
3 Nov 2023
INGRAM DOUGLAS S
President & CEO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
375,163
+7%
25,225
$79.36
$2,001,799.90
BUY
14 Aug 2023
Chambers Michael Andrew
Director
Sarepta Therapeutics, Inc.
(SRPT)
242,964
+4%
9,979
$109.47
$1,092,429.40
BUY
11 Aug 2023
Chambers Michael Andrew
Director
Sarepta Therapeutics, Inc.
(SRPT)
237,017
+11%
23,686
$108.05
$2,559,272.20
BUY
10 Aug 2023
Chambers Michael Andrew
Director
Sarepta Therapeutics, Inc.
(SRPT)
180,670
+23%
34,867
$106.15
$3,701,067.20
SELL
4 Aug 2023
Wigzell Hans Lennart Rudolf
Director
Sarepta Therapeutics, Inc.
(SRPT)
20,994
-41%
15,000
$106.72
$1,600,800.00
BUY
14 Jul 2023
Josh Gottheimer
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
13 Jun 2023
Josh Gottheimer
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
10 Apr 2023
Daniel Goldman
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$15,001 - 50,000
BUY
6 Mar 2023
Daniel Goldman
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$15,001 - 50,000
BUY
6 Mar 2023
Josh Gottheimer
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
31 Jan 2023
Daniel Goldman
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
17 Nov 2022
Mayo Stephen
Director
Sarepta Therapeutics, Inc.
(SRPT)
6,387
-11%
858
$109.92
$94,311.36
BUY
14 Sep 2022
Chambers Michael Andrew
Director
Sarepta Therapeutics, Inc.
(SRPT)
71,822
+387%
57,100
$104.43
$5,963,124.00
BUY
19 Aug 2022
Chambers Michael Andrew
Director
Sarepta Therapeutics, Inc.
(SRPT)
45,018
+4007%
46,170
$108.28
$4,999,230.00
BUY
24 Nov 2021
Rodino-Klapac Louise
Head of R&D, CSO, Officer
Sarepta Therapeutics, Inc.
(SRPT)
65,678
+6%
3,780
$79.33
$299,867.40
BUY
17 Nov 2021
INGRAM DOUGLAS S
President & CEO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
365,082
+7%
25,026
$79.94
$2,000,578.50
SELL
10 Mar 2021
BEHRENS M KATHLEEN
Director
Sarepta Therapeutics, Inc.
(SRPT)
130,517
-3%
5,000
$85.76
$428,800.00
SELL
8 Mar 2021
Wigzell Hans Lennart Rudolf
Director
Sarepta Therapeutics, Inc.
(SRPT)
16,518
-37%
10,000
$83.51
$835,100.00
SELL
11 Dec 2020
Bratica Joseph
Principal Financial Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
8,140
-12%
1,115
$165.00
$183,975.00
SELL
8 Dec 2020
Bratica Joseph
Principal Financial Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
8,140
-12%
1,125
$160.00
$180,000.00
SELL
6 Nov 2020
Josh Gottheimer
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
BUY
14 Sep 2020
Gilbert Cisneros
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
10 Aug 2020
Wigzell Hans Lennart Rudolf
Director
Sarepta Therapeutics, Inc.
(SRPT)
14,569
-40%
10,000
$159.00
$1,590,043.90
SELL
7 Aug 2020
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
3,132,280
-0%
30,000
$158.50
$4,754,972.00
SELL
3 Aug 2020
Bratica Joseph
Principal Financial Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
7,832
-12%
1,125
$155.00
$174,375.00
SELL
22 Jun 2020
Howton David T
EVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
130,984
-44%
105,122
$170.88
$17,962,832.00
SELL
10 Jun 2020
Gilbert Cisneros
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
20 May 2020
Wigzell Hans Lennart Rudolf
Director
Sarepta Therapeutics, Inc.
(SRPT)
16,692
-23%
5,000
$150.64
$753,209.70
SELL
15 May 2020
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
3,163,813
-0%
30,000
$141.26
$4,237,945.50
SELL
4 Mar 2020
Wigzell Hans Lennart Rudolf
Director
Sarepta Therapeutics, Inc.
(SRPT)
13,792
-26%
5,000
$116.89
$584,450.00
SELL
13 Dec 2019
Howton David T
EVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
25,171
-75%
78,000
$125.50
$9,789,000.00
SELL
13 Dec 2019
Cumbo Alexander
EVP, Chief Commercial Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
11,161
-79%
42,000
$125.50
$5,271,000.00
SELL
13 Dec 2019
Mahatme Sandesh
EVP, CFO & CBO, Officer
Sarepta Therapeutics, Inc.
(SRPT)
30,179
-80%
125,000
$125.50
$15,687,500.00
BUY
13 Dec 2019
Josh Gottheimer
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
22 Nov 2019
Howton David T
EVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
18,703
-57%
25,000
$105.00
$2,625,000.00
BUY
11 Oct 2019
Gilbert Cisneros
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
BUY
10 Oct 2019
Gilbert Cisneros
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
BUY
12 Sep 2019
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
3,187,065
+0%
5,000
$87.49
$437,454.88
BUY
9 Sep 2019
BONNEY MICHAEL W
Director
Sarepta Therapeutics, Inc.
(SRPT)
7,051
+39%
2,000
$86.74
$173,480.00
BUY
5 Sep 2019
BEHRENS M KATHLEEN
Director
Sarepta Therapeutics, Inc.
(SRPT)
125,667
+2%
2,500
$87.98
$219,950.02
BUY
20 Aug 2019
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
3,182,065
+0%
5,000
$99.32
$496,592.47
BUY
14 Aug 2019
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
3,177,065
+0%
3,700
$122.50
$453,250.00
BUY
12 Aug 2019
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
3,173,365
+0%
1,300
$122.50
$159,250.00
BUY
12 Aug 2019
INGRAM DOUGLAS S
President & CEO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
424,405
+3%
16,252
$123.07
$2,000,160.40
SELL
23 May 2019
Wigzell Hans Lennart Rudolf
Director
Sarepta Therapeutics, Inc.
(SRPT)
11,717
-46%
10,000
$120.00
$1,200,000.00
BUY
9 Apr 2019
Gilbert Cisneros
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
BUY
11 Mar 2019
Gilbert Cisneros
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
BUY
27 Feb 2019
Gilbert Cisneros
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
BUY
26 Feb 2019
Gilbert Cisneros
Congressman (House)
Sarepta Therapeutics, Inc.
(SRPT)
N/A
N/A
N/A
$1,001 - $15,000
SELL
7 Feb 2019
Mahatme Sandesh
EVP, CFO & CBO, Officer
Sarepta Therapeutics, Inc.
(SRPT)
8,649
-88%
65,000
$145.00
$9,425,000.00
SELL
1 Feb 2019
Howton David T
SVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
19,571
-60%
30,000
$140.00
$4,200,000.00
SELL
1 Feb 2019
Cumbo Alexander
SVP, Chief Commercial Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
15,266
-49%
15,000
$140.00
$2,100,000.00
SELL
30 Jan 2019
Mahatme Sandesh
EVP, CFO & CBO, Officer
Sarepta Therapeutics, Inc.
(SRPT)
8,649
-88%
65,000
$130.23
$8,465,262.00
SELL
1 Nov 2018
Wigzell Hans Lennart Rudolf
Director
Sarepta Therapeutics, Inc.
(SRPT)
10,084
-39%
6,667
$140.50
$936,713.50
SELL
31 Oct 2018
BEHRENS M KATHLEEN
Director
Sarepta Therapeutics, Inc.
(SRPT)
116,534
-7%
10,000
$131.71
$1,317,100.10
BUY
30 Oct 2018
INGRAM DOUGLAS S
President & CEO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
412,811
+4%
16,695
$120.39
$2,009,871.90
SELL
24 Oct 2018
Mahatme Sandesh
EVP, CFO & CBO, Officer
Sarepta Therapeutics, Inc.
(SRPT)
20,661
-83%
107,524
$127.74
$13,735,116.00
BUY
15 Aug 2018
INGRAM DOUGLAS S
President & CEO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
399,250
+4%
16,000
$125.26
$2,004,211.10
SELL
16 Jul 2018
Howton David T
SVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
34,871
-58%
50,000
$136.46
$6,823,000.50
SELL
9 Jul 2018
Cumbo Alexander
SVP, Chief Commercial Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
28,766
-54%
33,782
$137.32
$4,638,944.50
SELL
27 Jun 2018
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
3,170,432
-2%
75,000
$130.34
$9,775,500.00
SELL
30 Nov 2017
Wigzell Hans Lennart Rudolf
Director
Sarepta Therapeutics, Inc.
(SRPT)
6,666
-50%
6,667
$55.89
$372,618.62
BUY
8 Nov 2017
INGRAM DOUGLAS S
President & CEO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
420,196
+9%
38,138
$52.44
$1,999,956.60
SELL
6 Nov 2017
Ruff Shamim
SVP, Regulatory Affairs & Qual, Officer
Sarepta Therapeutics, Inc.
(SRPT)
27,045
-26%
10,000
$55.00
$550,000.00
SELL
3 Oct 2017
Ruff Shamim
SVP, Regulatory Affairs & Qual, Officer
Sarepta Therapeutics, Inc.
(SRPT)
27,045
-29%
11,500
$50.00
$575,000.00
BUY
27 Jul 2017
INGRAM DOUGLAS S
President & CEO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
382,058
+14%
47,058
$42.50
$1,999,965.00
SELL
20 Jul 2017
Howton David T
SVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
22,301
-52%
25,000
$41.00
$1,025,000.00
SELL
20 Jul 2017
Cumbo Alexander
SVP, Chief Commercial Officer, Officer
Sarepta Therapeutics, Inc.
(SRPT)
20,293
-22%
5,918
$41.00
$242,638.00
SELL
20 Jul 2017
Mahatme Sandesh
EVP, CFO & CBO, Officer
Sarepta Therapeutics, Inc.
(SRPT)
32,361
-60%
50,000
$41.00
$2,050,000.00
SELL
20 Jul 2017
Kaye Edward M. MD
Director
Sarepta Therapeutics, Inc.
(SRPT)
52,471
-16%
10,000
$41.00
$410,000.00
SELL
20 Jul 2017
Ruff Shamim
SVP, Regulatory Affairs & Qual, Officer
Sarepta Therapeutics, Inc.
(SRPT)
21,062
-30%
9,138
$42.97
$389,572.00
SELL
17 Oct 2016
Mahatme Sandesh
Senior Vice President, CFO, Officer
Sarepta Therapeutics, Inc.
(SRPT)
31,532
-48%
30,000
$50.08
$1,502,502.00
SELL
22 Sep 2016
Howton David T
SVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
21,453
-24%
7,000
$60.00
$420,000.00
SELL
22 Sep 2016
Ruff Shamim
SVP, Regulatory Affairs & Qual, Officer
Sarepta Therapeutics, Inc.
(SRPT)
20,239
-26%
7,311
$60.00
$438,660.00
SELL
22 Sep 2016
Kaye Edward M. MD
President, CEO & CMO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
76,983
-34%
40,179
$60.00
$2,410,740.00
SELL
19 Sep 2016
Howton David T
SVP, General Counsel, Officer
Sarepta Therapeutics, Inc.
(SRPT)
3,168
-74%
9,304
$50.00
$465,200.00
SELL
19 Sep 2016
Aphale Jayant
VP, Technical Operations, Officer
Sarepta Therapeutics, Inc.
(SRPT)
11,490
-75%
35,000
$50.00
$1,750,000.00
SELL
19 Sep 2016
Kaye Edward M. MD
President, CEO & CMO, Director, Officer
Sarepta Therapeutics, Inc.
(SRPT)
76,983
-24%
24,352
$50.00
$1,217,600.00
SELL
14 Sep 2016
Kaye Edward M. MD
SVP Interim CEO & CMO, Officer
Sarepta Therapeutics, Inc.
(SRPT)
76,983
-24%
24,557
$30.00
$736,710.00
BUY
14 Mar 2016
Price Ben Gil
Director
Sarepta Therapeutics, Inc.
(SRPT)
42,830
+11%
4,500
$16.70
$75,144.15
BUY
14 Mar 2016
BEHRENS M KATHLEEN
Director
Sarepta Therapeutics, Inc.
(SRPT)
21,855
+141%
75,000
$16.28
$1,220,708.50
BUY
14 Mar 2016
Barry Richard
Director
Sarepta Therapeutics, Inc.
(SRPT)
3,241,014
+2%
75,000
$15.66
$1,174,185.00
Home